Cardioprotective effects of Dexmedetomidine in patients with Ischemic Heart Disease

Cardioprotective effects of Dexmedetomidine in patients with Ischemic Heart Disease undergoing elective lumbar spine fixation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201711002757295

Enrollment

Registered

2017-11-13

Start date

2015-06-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulatory System patients with Ischemic Heart Disease Cardiology

Interventions

Group D

Group S

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ¿ Patients(45 -65 years) ¿ Normal preoperative Troponine I and CKMB levels ¿ Patients on preoperative statin and B blockers

Exclusion criteria

Exclusion criteria: 1. Patients with acute myocardial infarction, 2. Congestive heart failure 3. Heart block 4. Unstable angina 5. Significant arrhythmia 6. EF¿ 50% 7. Previous CABAG 8. Diabetic patients 9. Uncontrolled hypertension 10. Epileptic patients 11. Patients with known allergies to the studied drugs 12. Severe hepatic, renal, or CNS involvement 13. Pregnant 14. Patients on opioids or alcohol use

Design outcomes

Primary

Measure	Time frame
Troponin I	—

Countries

Egypt

Contacts

Public Contactdoaa rashwan

Assistant professor Faculty of medicine, Beni Sueif University

doaa_rashwan@hotmail.com01011270763

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026